![Leverne Marsh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leverne Marsh
Corporate Officer/Principal chez
PHARMING GROUP N.V.
Profil
Leverne Marsh is currently Chief Commercial Officer at Pharming Group NV since 2026.
Former positions include Executive Vice President-Marketing at DexCom, Inc. and Chief Product Officer & SVP-Pharma Strategy at Novartis AG.
Education includes an undergraduate degree from Nelson Mandela Metropolitan University.
Postes actifs de Leverne Marsh
| Sociétés | Poste | Début |
|---|---|---|
| PHARMING GROUP N.V. | Corporate Officer/Principal | 01/01/2026 |
Anciens postes connus de Leverne Marsh
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
| DEXCOM, INC. | Sales & Marketing | - |
Formation de Leverne Marsh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Nelson Mandela Metropolitan University
 Nelson Mandela Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
